Article Information
History
- November 15, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- T.S. Selvavinayagam1,
- A. Somasundaram1,
- Jerard Maria Selvam1,
- Sabareesh Ramachandran2,
- P. Sampath1,
- V. Vijayalakshmi1,
- C. Ajith Brabhu Kumar1,
- Sudharshini Subramaniam1,
- S Raju1,
- R Avudaiselvi1,
- V. Prakash1,
- N. Yogananth1,
- Gurunathan Subramanian,
- A Roshini1,
- D.N. Dhiliban1,
- Sofia Imad3,
- Vaidehi Tandel4,
- Rajeswari Parasa3,
- Stuti Sachdeva4 and
- Anup Malani4,*
- 1Directorate of Public Health & Preventative Medicine, Government of Tamil Nadu
- 2University of California, San Diego
- 3IDFC Institute
- 4independent
- 5University of Chicago
- ↵*Corresponding author (amalani{at}uchicago.edu).
Posted November 15, 2021.
Seroprevalence in Tamil Nadu through India’s two COVID waves: Evidence on antibody decline following infection and vaccination
